MiMedx Completes Divestiture

MiMedx Completes Divestiture Of Its Stability Biologics Subsidiary

MARIETTA, Ga., Oct. 2, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics…